Ignite Creation Date:
2024-05-05 @ 11:47 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00134485
Status:
COMPLETED
Last Update Posted:
2007-10-30
First Post:
2005-08-22
Brief Title:
Study To Evaluate The Safety And Efficacy Of TorcetrapibAtorvastatin In Subjects With Familial Hypercholerolemia
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
Phase 3 Multi-Center Double-Blind Randomized Parallel Group Study of the Efficacy Safety and Tolerability of Fixed Combination Torcetrapib CP-529414 Atorvastatin Administered Orally Once Daily QD for Six Months Compared With Maximally Tolerated Atorvastatin Therapy Alone in Subjects With Heterozygous Familial Hypercholesterolemia
Status:
COMPLETED
Status Verified Date:
2006-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The Torcetrapib project was terminated on December 2 2006 due to safety findings
To evaluate the efficacy and safety of torcetrapibatorvastatin compared to atorvastatin alone in patients with heterozygous familial hypercholesterolemia
To evaluate the efficacy and safety of torcetrapibatorvastatin compared to atorvastatin alone in patients with heterozygous familial hypercholesterolemia
Detailed Description:
For additional information please call 1-800-718-1021
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None